Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy.

IF 4.3 3区材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC

ACS Applied Electronic Materials Pub Date : 2024-08-01 Epub Date: 2024-06-12 DOI:10.1007/s11886-024-02078-7

Arka Chatterjee, Madhan Shanmugasundaram, Kwan S Lee, Toshinobu Kazui, Indranee N Rajapreyar, Deepak Acharya

{"title":"Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy.","authors":"Arka Chatterjee, Madhan Shanmugasundaram, Kwan S Lee, Toshinobu Kazui, Indranee N Rajapreyar, Deepak Acharya","doi":"10.1007/s11886-024-02078-7","DOIUrl":null,"url":null,"abstract":"Purpose of review: Cardiac Allograft vasculopathy (CAV) is a major barrier to improving outcomes after heart transplantation. Coronary angiography has very low sensitivity to detect early CAV and intravascular ultrasound (IVUS) only improves it to some extent. In this article, we detail the current evidence surrounding use of Optical Coherence tomography (OCT) in patients with CAV.Recent findings: OCT has the ability to recognize CAV at earlier stages with intimal thickness < 150 μm, can characterize CAV in almost pathologic / microscopic detail - plaque characteristics are better visualized and novel early features such as layered fibrotic plaques and microchannels have been identified. Progression of CAV can be monitored also, with promise shown in automated serial measurements also. OCT has significantly advanced our understanding of the pathophysiology-as well as permits precise monitoring and surveillance of the disease. Potential treatment options could also be evaluated using OCT.","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11886-024-02078-7","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Cardiac Allograft vasculopathy (CAV) is a major barrier to improving outcomes after heart transplantation. Coronary angiography has very low sensitivity to detect early CAV and intravascular ultrasound (IVUS) only improves it to some extent. In this article, we detail the current evidence surrounding use of Optical Coherence tomography (OCT) in patients with CAV.

Recent findings: OCT has the ability to recognize CAV at earlier stages with intimal thickness < 150 μm, can characterize CAV in almost pathologic / microscopic detail - plaque characteristics are better visualized and novel early features such as layered fibrotic plaques and microchannels have been identified. Progression of CAV can be monitored also, with promise shown in automated serial measurements also. OCT has significantly advanced our understanding of the pathophysiology-as well as permits precise monitoring and surveillance of the disease. Potential treatment options could also be evaluated using OCT.

Abstract Image

查看原文本刊更多论文

光学相干断层扫描在心脏移植血管病变评估和管理中的应用。

综述目的：心脏移植血管病变（CAV）是改善心脏移植后预后的主要障碍。冠状动脉造影术检测早期 CAV 的灵敏度非常低，血管内超声（IVUS）也只能在一定程度上改善其灵敏度。在本文中，我们将详细介绍有关在 CAV 患者中使用光学相干断层扫描（OCT）的现有证据：光学相干断层扫描（OCT）有能力识别早期的 CAV，其内膜厚度可与血管超声（IVUS）相媲美。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Electronic Materials Multiple-

CiteScore

7.20

自引率

4.30%

发文量

567